{"transactions":[{"id":753110,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T20:48:26.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":9136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from June 2, 2026."}],"balance_after":9136,"derivative":{"exercise_price":55.23,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":9136},"source":{"system":"sec-edgar","filing":"0000907654-26-000049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000049/form4.xml","form_type":"4"}},{"id":1126283,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:10:55.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from June 2, 2025."}],"balance_after":17500,"derivative":{"exercise_price":11.77,"expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001062993-25-010822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000106299325010822/form4.xml","form_type":"4"}},{"id":1854104,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T18:02:47.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":1.18,"expiration_date":"2023-06-12","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-037515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000120919123037515/doc4.xml","form_type":"4"}},{"id":2235705,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T18:47:17.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":2.09,"expiration_date":"2032-06-07","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-036109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000120919122036109/doc4.xml","form_type":"4"}},{"id":2671642,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T16:35:20.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-06-08","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-039850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000120919121039850/doc4.xml","form_type":"4"}},{"id":3110355,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T17:12:48.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":17.87,"expiration_date":"2030-06-09","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-036674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000120919120036674/doc4.xml","form_type":"4"}},{"id":3138913,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-21T18:31:20.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the Option vests in equal annual installments as measured from 5/20/2020."}],"balance_after":24000,"derivative":{"exercise_price":18.41,"expiration_date":"2030-05-19","underlying":"Class A Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-20-031451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000120919120031451/doc4.xml","form_type":"4"}},{"id":3180688,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:20:39.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":10322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\"), upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting on the one-year anniversary of the grant date, subject to Reporting Person's continuous service on such date, was canceled in the Merger in exchange for a cash payment of $874,170.18, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting on the one-year anniversary of the grant date, subject to Reporting Person's continuous service on such date, was canceled in the Merger in exchange for a cash payment of $874,170.18, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":10322},"source":{"system":"sec-edgar","filing":"0001209191-20-023717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023717/doc4.xml","form_type":"4"}},{"id":3180687,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-07T12:20:39.000Z","date":"2020-04-07","kind":"disposition_to_issuer","acquired":false,"shares":69677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. (\"Gilead\") and Toro Merger Sub, Inc. (\"Purchaser\") (the \"Merger\"), upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the \"Offer to Purchase\") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning February 1, 2018, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,043,957.17, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning February 1, 2018, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $6,043,957.17, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option."}],"balance_after":0,"derivative":{"exercise_price":8.7575,"expiration_date":"2028-03-19","underlying":"Common Stock","underlying_shares":69677},"source":{"system":"sec-edgar","filing":"0001209191-20-023717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919120023717/doc4.xml","form_type":"4"}},{"id":3340753,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-12-16T17:14:49.000Z","date":"2019-12-11","kind":"exercise","acquired":false,"shares":80300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":80300},"source":{"system":"sec-edgar","filing":"0000899243-19-029293","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319029293/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3340752,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common stock","published_at":"2019-12-16T17:14:49.000Z","date":"2019-12-11","kind":"tax_withholding","acquired":false,"shares":27766,"price":4.52,"value":125502.32,"ownership":{"direct":true},"balance_after":52534,"source":{"system":"sec-edgar","filing":"0000899243-19-029293","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319029293/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3340751,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common stock","published_at":"2019-12-16T17:14:49.000Z","date":"2019-12-11","kind":"exercise","acquired":true,"shares":80300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."}],"balance_after":80300,"source":{"system":"sec-edgar","filing":"0000899243-19-029293","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319029293/doc4a.xml","form_type":"4/A","original_submission_date":"2019-12-16"}},{"id":3342183,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common stock","published_at":"2019-12-13T21:56:40.000Z","date":"2019-12-11","kind":"tax_withholding","acquired":false,"shares":27766,"price":4.52,"value":125502.32,"ownership":{"direct":true},"balance_after":52534,"source":{"system":"sec-edgar","filing":"0000899243-19-029188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319029188/doc4.xml","form_type":"4"}},{"id":3342182,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common stock","published_at":"2019-12-13T21:56:40.000Z","date":"2019-12-11","kind":"exercise","acquired":true,"shares":80300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 29, 2019, the Reporting Person was granted 80,300 restricted stock units (\"RSUs\"), for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs were scheduled to vest in two (2) equal annual installments beginning July 29, 2020. The vesting of the RSUs was accelerated in full on December 11, 2019 in connection with the pending transactions contemplated by the Agreement and Plan of Merger entered into on November 10, 2019 among the Issuer, Foamix Pharmaceuticals Ltd and Giants Merger Subsidiary Ltd., a wholly-owned subsidiary of the Issuer, in order to mitigate potential negative tax consequences to both the Issuer and the Reporting Person under Section 280G and 4999 of the Internal Revenue Code."}],"balance_after":80300,"source":{"system":"sec-edgar","filing":"0000899243-19-029188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319029188/doc4.xml","form_type":"4"}},{"id":3444419,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-08-07T19:27:27.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":80300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":413423,"derivative":{"underlying":"Common Stock","underlying_shares":80300},"source":{"system":"sec-edgar","filing":"0000899243-19-021295","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319021295/doc4a.xml","form_type":"4/A","original_submission_date":"2019-07-31"}},{"id":3451895,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2019-07-31T18:35:24.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":80300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable"}],"balance_after":413423,"derivative":{"underlying":"Common Stock","underlying_shares":80300},"source":{"system":"sec-edgar","filing":"0000899243-19-020703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000089924319020703/doc4.xml","form_type":"4"}},{"id":3489651,"issuer":{"id":16035,"kind":"organization","name":"Forty Seven, Inc.","symbol":"FTSV"},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T18:09:05.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":10322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the one-year anniversary of the grant date, subject to Reporting Person's continuous service on such date."}],"balance_after":10322,"derivative":{"exercise_price":10.81,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":10322},"source":{"system":"sec-edgar","filing":"0001209191-19-037265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667633/000120919119037265/doc4.xml","form_type":"4"}},{"id":3733863,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corporate Strategy & CFO"}}],"security":"Stock Option","published_at":"2018-12-12T18:41:35.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly."}],"balance_after":96000,"derivative":{"exercise_price":5.51,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001566044-18-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000156604418000010/edgardoc.xml","form_type":"4"}},{"id":3945405,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":42002,"kind":"person","name":"BALL KRISTINE M","position":1,"cik":"0001266163","reported_name":"BALL KRISTINE M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2018-05-04T16:34:18.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly."}],"balance_after":237123,"derivative":{"exercise_price":8.49,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001209191-18-028121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266163/000120919118028121/doc4.xml","form_type":"4"}}]}